Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.
Daily MedNews
-- Here are the latest clinical trials, courtesy of CenterWatch:
Healthy Patient Studies
If you are aged 18 to 65, healthy, a non-smoker, and able to stay at the clinic and make outpatient visits, you may qualify for this study. Women must be...
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Nobel Prize for AIDS, Cervical Cancer Virus Discoveries
The 2008 Nobel Prize in medicine was awarded Monday to three European researchers for their...
MONDAY, Oct. 6 -- Variants in the gene that helps produce vital proteins in the eye have been linked to age-related macular degeneration (AMD), a major source of blindness, a new report says.
Visual impairment or blindness from AMD is common in...
MONDAY, Oct. 6 -- Stimulant treatment for attention-deficit hyperactivity disorder (ADHD) significantly cuts the odds that adolescent girls will smoke, drink alcohol or use drugs, a new Massachusetts General Hospital study shows.
The finding...
MONDAY, Oct. 6 -- Being vaccinated against pneumonia halves the risk of having a heart attack two years later, a new Canadian study finds.
The study compared 999 people admitted to Canadian hospitals for heart attacks, with 3,996 admitted for other...
Pharma Industry News
Results published in New England Journal of Medicine reaffirm well-established efficacy and long-term safety profile of SPIRIVA(R) HandiHaler(R)
RIDGEFIELD, Conn., and NEW YORK, Oct. 5 /PRNewswire/ -- Results of the UPLIFT (Understanding Potential...
GENEVA, Switzerland, October 2/PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that Genentech Inc. has reported a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had...
SOUTH SAN FRANCISCO, Calif. -- October 2, 2008 -- Genentech, Inc. (NYSE: DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal...
WHITEHOUSE STATION, N.J., Oct. 2, 2008--(BUSINESS WIRE)--Merck & Co., Inc. will not seek regulatory approval for taranabant, an investigational medicine, to treat obesity and is discontinuing its Phase III clinical development program for...
WASHINGTON, October 1, 2008— According to a new survey released by the National Consumers League (NCL) today, nearly three-quarters of prescription drug users would be very concerned if a drug they were prescribed was switched to another drug...
New Drug Approvals
PRINCETON, N.J., Oct. 1, 2008-- BUSINESS WIRE --Bristol-Myers Squibb Company announced today that the U.S. Food & Drug Administration (FDA) approved the use of Reyataz (atazanavir sulfate) 300 mg once-daily boosted with ritonavir 100 mg as part of...
INDIANAPOLIS, Sept. 29 /PRNewswire-FirstCall/ -- Eli Lilly and Company announced today it received approval from the U.S. Food and Drug Administration (FDA) for the use of Alimta (pemetrexed for injection), in combination with cisplatin, in the...
Company also announces FDA approval of TAXUS Express2 Stent System for treatment of in-stent restenosis
NATICK, Mass., September 25, 2008 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that it has received approval from the...
JERUSALEM--(BUSINESS WIRE)--Sept. 23, 2008 - Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved ProAir HFA (albuterol sulfate) Inhalation Aerosol for use in patients as young as 4 years...
BRIDGEWATER, N.J., September 23, 2008 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today the U.S. Food and Drug Administration (FDA) has approved Nasacort AQ Nasal Spray (triamcinolone acetonide) for children aged 2-5 years old for the...
New Drug Applications
DEERFIELD, Ill., Oct. 6, 2008--BUSINESS WIRE-OVATION Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for ATryn (antithrombin alfa). OVATION...
PT. RICHMOND, Calif., Oct. 1 /PRNewswire/ -- Transcept Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for...
HUDDINGE, Sweden, Oct. 1, 2008-Medivir has today submitted an NDA to the US Food & Drug Administration (FDA) for Lipsovir, a topical product for prevention and treatment of cold sores. Lipsovir is a patented combination of hydrocortisone (an...
CHICAGO, Oct. 1 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. today announced the submission of a new drug application (NDA) for cethromycin in mild-to-moderate community acquired pneumonia (CAP). Advanced Life Sciences also...
TOKYO and INDIANAPOLIS, Sept. 26 /PRNewswire-FirstCall/ -- Daiichi Sankyo Company, Limited, and Eli Lilly and Company confirmed today that the U.S. Food and Drug Administration (FDA) did not complete its review for the prasugrel new drug application...
Clinical Trials
CX717 Prevents Opioid-Induced Respiratory Depression While Maintaining Analgesia
IRVINE, Calif., Oct. 6, 2008--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (NYSE Alternext US (COR)) reported that top-line data from its second Phase IIa study in...
Presentation at the Obesity Society Annual Scientific Meeting Shows Weight Loss of 17 Pounds in 28 Weeks
MOUNTAIN VIEW, Calif., Oct. 6, 2008--(BUSINESS WIRE)--VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and...
TAK-390MR Data Presented at the American College of Gastroenterology Annual Meeting
ORLANDO, Fla., Oct. 6 /PRNewswire/ -- Combined results from two Phase 3 studies presented at the American College of Gastroenterology Annual Scientific Meeting (ACG)...
Results of 5,993 patient study UPLIFT(R) (Understanding Potential Long-term Impacts on Function with Tiotropium) presented today at European
BERLIN, Oct. 6 /PRNewswire/ -- Results of the UPLIFT(R) trial, presented today at the European Respiratory...
Results Presented at American College of Gastroenterology Annual Meeting Demonstrate Quality of Life Benefits and IBS Symptom Severity as Predictor of Clinical Response
ORLANDO, Fla., Oct. 6, 2008--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd....
More News Resources
Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals
